Article info
Uterine Cancer
Utility of Tumor Marker HE4 to Predict Depth of Myometrial Invasion in Endometrioid Adenocarcinoma of the Uterus
- Address correspondence and reprint requests to Richard G. Moore, MD, Center for Biomarkers and Emerging Technologies and Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, 101 Dudley St, Providence, RI 02905. E-mail: rmoore{at}wihri.org.
Citation
Utility of Tumor Marker HE4 to Predict Depth of Myometrial Invasion in Endometrioid Adenocarcinoma of the Uterus
Publication history
- Received January 8, 2011
- First published October 1, 2011.
Online issue publication
October 01, 2011
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2011 by IGCS and ESGO